Indivior (LON:INDV) Shares Down 20.6% - What's Next?

Indivior PLC (LON:INDV - Get Free Report) fell 20.6% during trading on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 689.44 ($8.71). 2,685,740 shares changed hands during trading, an increase of 267% from the average session volume of 731,626 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reissued a "buy" rating and set a GBX 1,800 ($22.74) target price on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Stock Down 5.9 %

The firm has a market cap of £1.08 billion, a PE ratio of -570.87, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The business's 50-day simple moving average is GBX 920.11 and its 200 day simple moving average is GBX 850.81.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.